475-67-2
475-67-2
Chemical Structure
Isocorydine
- CAS No.: 475-67-2
- Formula:C20H23NO4
- Molecular Weight:341.40
IUPAC Name: (S)-1,2,10-trimethoxy-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinolin-11-ol
InChIKey: QELDJEKNFOQJOY-ZDUSSCGKSA-N
SMILES: COC1=C2C3=C(C=C1OC)CCN(C)[C@@]3([H])CC4=CC=C(OC)C(O)=C24
Biological Activity: Isocorydine is isolated from Dicranostigma leptopodum (Maxim.) Fedde (DLF). Isocorydine combines with Doxorubicin (DOX) has a promising potential to eradicate hepatocellular carcinoma (HCC)[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Isocorydine | 99.95% | Isocorydine is isolated from Dicranostigma leptopodum (Maxim.) Fedde (DLF). Isocorydine combines with Doxorubicin (DOX) has a promising potential to eradicate hepatocellular carcinoma (HCC). | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Isocorydine (Standard) | ≥98% | Isocorydine is isolated from Dicranostigma leptopodum (Maxim.) Fedde (DLF). Isocorydine combines with Doxorubicin (DOX) has a promising potential to eradicate hepatocellular carcinoma (HCC). | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
